undamentalytics Newsletter
Sign in

Hedge fund

Eversept Partners, LP

13F for the quarter to June 30, 2026, filed August 14, 2026 · SEC CIK 1697013

Reported value
$1.8bn
100% in companies we cover
Positions we cover
114
Largest UTHR 8.5%
Copy, a year
+30.4%
S&P 500 +21.4%
Copy Sharpe ratio
1.14
S&P 500 1.14

How copying its 13F would have done

$10.0k$20.0k 2023202420252026 $22.1k$17.8k
CopyS&P 500 $10,000 copying Eversept Partners, LP's filed holdings in companies we cover from November 10, 2023, buying on the first trading day after each 13F was filed and holding until the next, against the S&P 500 (total return). Marked weekly, log scale. Before costs and taxes; misses trading within each quarter and anything 13F does not show (shorts, cash, bonds, non-US holdings).

Biggest drop −21.7% (S&P 500 −16.9%); beta 0.84; alpha +10.9% a year (t = 1.06); last 12 months +15.4% against +12.1%.

Reported value by quarter

Eversept Partners, LP: 13F reported value Total value of all positions in each quarter's 13F, as filed (values before 2023 were filed in thousands of dollars and are converted).
$0 $500B $1T $1.5T Reported value, 2017-12-31: $149.8B Reported value, 2018-03-31: $198.4B Reported value, 2018-06-30: $204.1B Reported value, 2018-09-30: $199.2B Reported value, 2018-12-31: $180.3B Reported value, 2019-03-31: $337.8B Reported value, 2019-06-30: $350B Reported value, 2019-09-30: $319.1B Reported value, 2019-12-31: $491.9B Reported value, 2020-03-31: $379.8B Reported value, 2020-06-30: $605.5B Reported value, 2020-09-30: $444.1B Reported value, 2020-12-31: $832.7B Reported value, 2021-03-31: $1.2T Reported value, 2021-06-30: $1.1T Reported value, 2021-09-30: $1.2T Reported value, 2021-12-31: $1.2T Reported value, 2022-03-31: $1.1T Reported value, 2022-06-30: $1T Reported value, 2022-09-30: $843.2B Reported value, 2022-12-31: $1.1T Reported value, 2023-03-31: $1.1B Reported value, 2023-06-30: $946.9M Reported value, 2023-09-30: $900.7M Reported value, 2023-12-31: $1B Reported value, 2024-03-31: $1.3B Reported value, 2024-06-30: $1.3B Reported value, 2024-09-30: $1.3B Reported value, 2024-12-31: $969.1M Reported value, 2025-03-31: $883.7M Reported value, 2025-06-30: $992.2M Reported value, 2025-09-30: $1.3B Reported value, 2025-12-31: $1.8B Reported value, 2026-03-31: $1.5B Reported value, 2026-06-30: $1.8B 2017-12-31 2019-09-30 2021-06-30 2023-03-31 2024-12-31 2026-06-30 $1.8B
View chart data
Period Reported value
2017-12-31 $149.8B
2018-03-31 $198.4B
2018-06-30 $204.1B
2018-09-30 $199.2B
2018-12-31 $180.3B
2019-03-31 $337.8B
2019-06-30 $350B
2019-09-30 $319.1B
2019-12-31 $491.9B
2020-03-31 $379.8B
2020-06-30 $605.5B
2020-09-30 $444.1B
2020-12-31 $832.7B
2021-03-31 $1.2T
2021-06-30 $1.1T
2021-09-30 $1.2T
2021-12-31 $1.2T
2022-03-31 $1.1T
2022-06-30 $1T
2022-09-30 $843.2B
2022-12-31 $1.1T
2023-03-31 $1.1B
2023-06-30 $946.9M
2023-09-30 $900.7M
2023-12-31 $1B
2024-03-31 $1.3B
2024-06-30 $1.3B
2024-09-30 $1.3B
2024-12-31 $969.1M
2025-03-31 $883.7M
2025-06-30 $992.2M
2025-09-30 $1.3B
2025-12-31 $1.8B
2026-03-31 $1.5B
2026-06-30 $1.8B

Holdings and moves

CompanyShare of portfolioValueSharesChange in shares
UTHRUnited Therapeutics Corp8.50%$155.9m287.7K+8.9% Added
ABVXAbivax S.a.6.64%$121.8m913.9K−2.2% Reduced
EHCEncompass Health Corp5.66%$103.8m1.03M+429.1% Added
ENSGEnsign Group, Inc5.26%$96.5m602.1K+3978.8% Added
VERAVera Therapeutics, Inc.5.18%$94.9m2.21M+1.8% Added
CLDXCelldex Therapeutics, Inc.3.62%$66.5m1.79M−0.1%
SNDXSyndax Pharmaceuticals Inc3.33%$61.2m2.80M−3.0% Reduced
BKDBrookdale Senior Living Inc.2.98%$54.6m3.40M−4.8% Reduced
IONSIonis Pharmaceuticals Inc2.87%$52.7m664.7K+5.2% Added
NTRANatera, Inc.2.60%$47.7m175.8K−54.3% Reduced
TVTXTravere Therapeutics, Inc.2.47%$45.4m799.0K+47.2% Added
CTRECaretrust Reit, Inc.2.36%$43.3m1.07MNew
HCAHCA Healthcare2.09%$38.3m98.3K+24.0% Added
PCVXVaxcyte, Inc.2.00%$36.6m630.0K−31.8% Reduced
LQDALiquidia Corp1.86%$34.2m428.7K−36.7% Reduced
CYHCommunity Health Systems Inc1.43%$26.3m7.86M−9.4% Reduced
GSKGSK plc1.38%$25.3m481.8K−73.0% Reduced
CHEChemed Corp1.33%$24.5m52.5K+69.1% Added
LLYLilly (Eli)1.31%$24.1m20.1K+5.9% Added
GERNGeron Corp1.31%$24.0m18.72M−0.6% Reduced
VKTXViking Therapeutics, Inc.1.28%$23.5m602.9K+152.2% Added
OHIOmega Healthcare Investors Inc1.26%$23.1m483.5K−17.4% Reduced
PODDInsulet Corporation1.24%$22.7m148.8K+3.7% Added
THCTenet Healthcare Corp1.17%$21.4m114.2K+287.0% Added
UNHUnitedHealth Group1.16%$21.3m51.1KNew
WELLWelltower1.08%$19.8m87.3K−51.7% Reduced
BBNXBeta Bionics, Inc.1.07%$19.6m1.25M−11.7% Reduced
COGTCogent Biosciences, Inc.1.03%$19.0m490.2KNew
BCRXBiocryst Pharmaceuticals Inc1.02%$18.7m1.87M−38.6% Reduced
MOHMolina Healthcare, Inc.1.00%$18.4m80.6K+145.6% Added
PNTGPennant Group, Inc.0.93%$17.0m460.3K+47.4% Added
LTCLTC Properties Inc0.88%$16.2m420.6K+31.0% Added
INSMInsmed Inc0.87%$15.9m149.2KNew
VRDNViridian Therapeutics, Inc.\de0.83%$15.3m831.1K+16.5% Added
BMRNBiomarin Pharmaceutical Inc0.78%$14.3m249.6K+20.1% Added
AMNAMN Healthcare Services Inc0.76%$13.9m428.5KNew
CELCCelcuity Inc.0.73%$13.4m127.9KNew
PHVSPharvaris N.V.0.73%$13.4m386.4K−5.1% Reduced
CTMXCytomx Therapeutics, Inc.0.73%$13.3m3.56M+11.6% Added
HUMHumana0.68%$12.4m31.2KNew
XENEXenon Pharmaceuticals Inc.0.65%$11.9m196.5K+51.7% Added
CRVSCorvus Pharmaceuticals, Inc.0.61%$11.2m748.0KNew
ASNDAscendis Pharma A/s0.60%$11.1m41.6KNew
BRKRBruker Corp0.60%$11.0m182.9K+56.3% Added
MRNAModerna0.58%$10.7m152.1K−4.7% Reduced
GPCRStructure Therapeutics Inc.0.57%$10.5m196.3K+42.2% Added
DFTXDefinium Therapeutics, Inc.0.56%$10.2m217.2K+35.1% Added
CMPSCompass Pathways plc0.52%$9.5m672.8K−0.8% Reduced
NAMSNewamsterdam Pharma Co N.V.0.51%$9.3m275.5K−3.6% Reduced
RVTYRevvity0.51%$9.3m83.6K−1.4% Reduced
PALIPalisade BIO, Inc.0.48%$8.7m4.18M−16.1% Reduced
ARDXArdelyx, Inc.0.47%$8.6m1.68M−24.7% Reduced
MLYSMineralys Therapeutics, Inc.0.46%$8.4m309.7KNew
RLAYRelay Therapeutics, Inc.0.44%$8.1m434.3K+60.4% Added
NVONovo Nordisk A S0.44%$8.1m169.2KNew
BHVNBiohaven Ltd.0.42%$7.7m515.8KNew
PTGXProtagonist Therapeutics, Inc0.39%$7.2m58.5KNew
ELVNEnliven Therapeutics, Inc.0.38%$6.9m136.6KNew
REPLReplimune Group, Inc.0.36%$6.5m590.3K+76.3% Added
LBRXLB Pharmaceuticals Inc0.33%$6.0m183.7K+83.3% Added
BEAMBeam Therapeutics Inc.0.31%$5.7m166.3KNew
NHINational Health Investors Inc0.29%$5.4m70.7KNew
RAREUltragenyx Pharmaceutical Inc.0.28%$5.1m154.1K+146.3% Added
PACSPacs Group, Inc.0.27%$5.0m117.4KNew
EQEquillium, Inc.0.27%$4.9m1.52M+1.5% Added
ANABAnaptysbio, Inc0.26%$4.7m70.0K+158.3% Added
NHCNational Healthcare Corp0.26%$4.7m22.1KNew
EYPTEyepoint, Inc.0.23%$4.3m297.7KNew
SNDASonida Senior Living, Inc.0.23%$4.2m102.6K+260.9% Added
GKOSGlaukos Corp0.22%$4.1m29.3K−51.3% Reduced
AGLAgilon Health, Inc.0.22%$4.1m37.8K−78.6% Reduced
ARQTArcutis Biotherapeutics, Inc.0.19%$3.5m135.4K−76.5% Reduced
TARSTarsus Pharmaceuticals, Inc.0.19%$3.5m55.7KNew
ANROAlto Neuroscience, Inc.0.18%$3.4m128.3K+2.5% Added
SPRYARS Pharmaceuticals, Inc.0.17%$3.0m377.0K+176.7% Added
IFRXInflarx N.V.0.16%$2.9m1.30M−25.8% Reduced
ISRGIntuitive Surgical0.16%$2.9m7.2K−34.9% Reduced
ALECAlector, Inc.0.16%$2.9m1.42M+5.4% Added
VORVor Biopharma Inc.0.15%$2.8m149.7KNew
DSGNDesign Therapeutics, Inc.0.15%$2.7m190.0KNew
KPTIKaryopharm Therapeutics Inc.0.15%$2.7m276.2K0.0%
PMVPPMV Pharmaceuticals, Inc.0.14%$2.5m1.89M−19.5% Reduced
CTNMContineum Therapeutics, Inc.0.13%$2.4m148.0K+1.1% Added
EVMNEvommune, Inc.0.13%$2.3m174.5K+219.1% Added
AMRNAmarin Corp plc\uk0.13%$2.3m145.3K−1.6% Reduced
SPRBSpruce Biosciences, Inc.0.12%$2.2m40.0KNew
RGENRepligen Corp0.11%$2.0m14.4K−88.1% Reduced
IVVDInvivyd, Inc.0.11%$2.0m2.24M−1.7% Reduced
PRQRProqr Therapeutics N.V.0.10%$1.9m1.02MNew
GRCEGrace Therapeutics, Inc.0.10%$1.8m772.9K+2.2% Added
AVRAnteris Technologies Global Corp.0.09%$1.6m166.2K−58.6% Reduced
VIRVir Biotechnology, Inc.0.09%$1.6m156.6K−37.3% Reduced
EDITEditas Medicine, Inc.0.08%$1.5m458.8K+57.7% Added
WHWKWhitehawk Therapeutics, Inc.0.08%$1.4m303.3K−1.1% Reduced
TECHBio-Techne0.07%$1.4m19.3K−84.7% Reduced
RVMDRevolution Medicines, Inc.0.07%$1.3m6.9KNew
SVRASavara Inc0.07%$1.3m204.4K−46.8% Reduced
SRZNSurrozen, Inc.0.07%$1.2m47.8K−18.5% Reduced
INOInovio Pharmaceuticals, Inc.0.06%$1.1m1.04M0.0%
PLRXPliant Therapeutics, Inc.0.06%$1.0m891.4K0.0%
HELPHelus Pharma Inc.0.05%$967,724146.4KNew
ODTXOdyssey Therapeutics, Inc.0.05%$929,10149.7KNew
ENGNEngene Therapeutics Inc.0.04%$812,380469.6KNew
BCYCBicycle Therapeutics PLC0.04%$808,632190.7K0.0%
LPCNLipocine Inc.0.04%$755,172295.0K0.0%
RLMDRelmada Therapeutics, Inc.0.04%$644,88993.2K−66.5% Reduced
EHTHEhealth, Inc.0.03%$603,232404.9K+83.3% Added
AKBAAkebia Therapeutics, Inc.0.03%$486,888427.1KNew
SSIISS Innovations International, Inc.0.03%$457,152110.2K0.0%
ASMBAssembly Biosciences, Inc.0.03%$453,69516.5K−59.6% Reduced
RVPRetractable Technologies Inc0.02%$418,262580.9K0.0%
SLQTSelectquote, Inc.0.01%$268,974319.8K−10.6% Reduced
GHRSGH Research PLC0.01%$233,1038.7KNew
AVTXAvalo Therapeutics, Inc.0.01%$184,80010.0KNew
CompanyBought (value)Shares
ENSGEnsign Group, Inc$94.1m587.3K
EHCEncompass Health Corp$84.2m832.8K
CTRECaretrust Reit, Inc.$43.3m1.07M
UNHUnitedHealth Group$21.3m51.1K
COGTCogent Biosciences, Inc.$19.0m490.2K
INSMInsmed Inc$15.9m149.2K
THCTenet Healthcare Corp$15.8m84.7K
TVTXTravere Therapeutics, Inc.$14.6m256.4K
VKTXViking Therapeutics, Inc.$14.2m363.8K
AMNAMN Healthcare Services Inc$13.9m428.5K
CELCCelcuity Inc.$13.4m127.9K
UTHRUnited Therapeutics Corp$12.7m23.4K
HUMHumana$12.4m31.2K
CRVSCorvus Pharmaceuticals, Inc.$11.2m748.0K
ASNDAscendis Pharma A/s$11.1m41.6K

Change in shares on the previous quarter's 13F, valued at this quarter's reported price.

CompanySold (value)Shares
GSKGSK plc−$68.3m−1.30M
NTRANatera, Inc.−$56.7m−208.9K
DOCHealthpeak Properties−$32.5m−1.98M
AVTRAvantor, Inc.−$23.3m−2.97M
QGENQiagen N.V.−$21.8m−545.3K
WELLWelltower−$21.3m−93.6K
LQDALiquidia Corp−$19.8m−248.7K
PCVXVaxcyte, Inc.−$17.1m−294.2K
AGLAgilon Health, Inc.−$14.9m−138.8K
RGENRepligen Corp−$14.5m−106.4K
BCRXBiocryst Pharmaceuticals Inc−$11.7m−1.17M
ARQTArcutis Biotherapeutics, Inc.−$11.6m−441.2K
ICLRIcon PLC−$7.6m−68.7K
TECHBio-Techne−$7.5m−106.6K
AGIOAgios Pharmaceuticals, Inc.−$6.8m−200.0K

Change in shares on the previous quarter's 13F, valued at this quarter's reported price.

CompanyValue last quarterShares
DOCHealthpeak Properties$32.5m1.98M
AVTRAvantor, Inc.$23.3m2.97M
QGENQiagen N.V.$21.8m545.3K
ICLRIcon PLC$7.6m68.7K
AGIOAgios Pharmaceuticals, Inc.$6.8m200.0K
MDGLMadrigal Pharmaceuticals, Inc.$5.2m10.0K
HQYHealthequity, Inc.$4.3m51.6K
CNCCentene Corporation$3.7m111.7K
STROSutro Biopharma, Inc.$1.8m73.2K
NVCRNovocure Ltd$1.5m134.9K
BVSBioventus Inc.$1.5m159.1K
IMCRImmunocore Holdings plc$1.2m39.2K
TYRATyra Biosciences, Inc.$1.0m27.1K
DHCDiversified Healthcare Trust$1.0m151.3K
INMDInmode Ltd.$926,73867.7K
AIRSAirsculpt Technologies, Inc.$209,81374.1K
  • Health Care94.1%
  • Real Estate5.9%
  • Financials0.0%

Share of the value held in companies we cover, by sector.

PeriodCopy, a yearS&P 500SharpeS&P 500Biggest dropBeta
Whole backtestNovember 10, 2023 to November 2, 2026+30.4%+21.4%1.141.14−21.7%0.84
Last yearNovember 7, 2025 to November 2, 2026+17.0%+14.2%0.650.84−13.9%0.75

From SEC Form 13F data sets. A 13F lists long positions in US-listed shares at the quarter's end, filed up to 45 days later; it does not show shorts, cash, bonds, non-US holdings or trades within the quarter. Positions in companies outside our coverage are not listed here. Research, not investment advice.